A pilot, parallel-group, randomised controlled trial on the effectiveness of 10% Formalin in the treatment of plantar warts.
Not Applicable
- Conditions
- plantar verrucae (viral warts on the feet)Skin - Dermatological conditions
- Registration Number
- ACTRN12610000679088
- Lead Sponsor
- Rolf Scharfbillig
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot yet recruiting
- Sex
- All
- Target Recruitment
- 32
Inclusion Criteria
plantar wart present on at least one foot, multiple warts will be treated as one person not one wart, willingness to participate in the study, ability to communicate in english
Exclusion Criteria
sensitivity to formalin, younger than four years of age, immunocompromised, vascular or neurologically compromised in feet
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method